-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Some drugs used to treat a variety of diseases, including cancer, may have side effects on the lungs, and the effects are greater than previously thought, according to a new study published by the University of Manchester.
researchers from the University of Manchester, the University of Leeds, the University of Sheffield and others combed through 156 research papers involving data on 6,200 patients, mainly to analyse mesothopathy caused by drugs. The study was published online in the international journal Journal of Clinical Medicine.
interstital pulmonary disease is inflammation of interstital tissue in the lungs. The team found that 27 drugs used to treat arthritis, cancer and heart disease, while highly effective, could also cause potential damage to the lungs, particularly interstitiotic lung disease caused by the drug.
report states that between 4.1 million and 12.4 million cases of mesothopathy are reported globally each year, and that drug-induced mesostrogensis accounts for about 3 to 5 per cent of all types of interstital pulmonary disease.
John Waterton of the University of Manchester, one of the authors of the report, stressed that patients can still use the drug safely, but that doctors should closely monitor and assess the side effects the drug may have on the patient's lungs. (Xinhua News Agency)
